NCT07769775

Brief Summary

Venipuncture is one of the most common and distressing needle-related procedures for children, often causing significant pain, fear, and anxiety. To minimize this procedural distress, effective non-pharmacological interventions are essential in pediatric nursing care.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2026

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 18, 2026

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Completed
Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

11 months

First QC Date

August 10, 2026

Last Update Submit

August 17, 2026

Conditions

Keywords

childpainfearanxietyvenipuncturemultisensory stimülation

Outcome Measures

Primary Outcomes (1)

  • Child's Pain Level

    Wong Baker Facial Pain Rating Scale The scale was developed by Donna Wong and Connie Morain Baker in 1981 and revised in 2013. This scale is used to assess pain in children aged 3-18 years. The scale is rated from 0 to 10. 0 indicates no pain, while 10 indicates the most severe pain. Pain is assessed based on facial expression.

    Baseline (upon arrival) and immediately before the clinical encounter (after multisensory stimulation).

Secondary Outcomes (1)

  • Child's Anxiety Level

    Baseline (upon arrival) and immediately before the clinical encounter (after multisensory stimulation).

Other Outcomes (1)

  • Child's Fear Level

    Baseline (upon arrival) and immediately before the clinical encounter (after multisensory stimulation).

Study Arms (1)

The Effect of Multisensory Stimulation During Venipuncture on Pain, Anxiety, and Fear in Children

EXPERIMENTAL

A Randomized Controlled Trial

Other: Multisensory stimulation

Interventions

Happy Senso Therapy foam is a gel with multisensory properties. It stimulates the senses of touch, sight, hearing, and smell simultaneously in a fun way. It is a material used for sensory stimulation. It provides a cooling and fun effect that feels like "popping candy" on your skin. It evaporates at the end of the ses-sion, leaving no residue. It does not require washing. It has been dermatologically tested. It is paraben-free and hypoallergenic. It is used in therapy applications, as a work, play, and educational material. It is noted to be useful for increasing the child's attention span to the ac-tivity, boosting motivation, and reducing pain and fear. It helps increase interaction between the nurse and the child.

The Effect of Multisensory Stimulation During Venipuncture on Pain, Anxiety, and Fear in Children

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 5 to 10 years
  • Having passed at least 2 hours since the most recent painful procedure
  • Provision of parental/guardian informed consent for participation

You may not qualify if:

  • Presence of visual or hearing impairment
  • Presence of intellectual/cognitive disability
  • Absence or lack of signed Parental Informed Consent Form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bilecik Seyh Edebali University

Bilecik, Turkey, Turkey (Türkiye)

Location

Related Publications (1)

  • No publications resulting from this study are available at this time as the trial is currently ongoing.

    RESULT

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assis Prof Dr

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 18, 2026

Study Start

October 1, 2025

Primary Completion

August 15, 2026

Study Completion

September 1, 2026

Last Updated

August 19, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) will not be made publicly available or shared for this study due to ethical considerations regarding participant confidentiality and the explicit terms of the informed consent protocol. Specifically: Informed Consent Constraints: The informed consent forms approved by the Institutional Review Board (IRB) / Ethics Committee and signed by the parents/guardians do not include permissions for raw, individual-level data sharing with external third parties or public repositories. Privacy and Vulnerability: Given that the study population consists of pediatric patients undergoing clinical evaluations, raw IPD contains sensitive demographic and clinical details that could potentially compromise participant anonymity. De-identified aggregate statistical data, protocol details, and final study findings will be made available through published peer-reviewed journal articles and clinical trial registries upon study completion.

Locations